Friday, July 10, 2026

Drug profile · INN

herceptin

herceptin is a receptor protein-tyrosine kinase erbb-2 inhibitor.

NMPA: clinical trials
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — herceptin
Class
Route
Patents
0
Programs
0
Data quality
0.70

Quick answer

herceptin is a receptor protein-tyrosine kinase erbb-2 inhibitor.

Key facts

INN herceptin
Mechanism Receptor protein-tyrosine kinase erbB-2 inhibitor
Target Receptor tyrosine-protein kinase erbB-2

Mechanism of action

Receptor protein-tyrosine kinase erbB-2 inhibitor

Primary target: Receptor tyrosine-protein kinase erbB-2

Approval history

Authority Status Date
NMPA clinical trials

Related & competitor drugs

  1. zanidatamab Antineoplastic and immunomodulating agents (L01)
  2. zanidatamab-hrii Receptor protein-tyrosine kinase erbB-2 inhibitor
  3. ado-trastuzumab emtansine Receptor protein-tyrosine kinase erbB-2 binding agent
  4. margetuximab-cmkb Receptor protein-tyrosine kinase erbB-2 inhibitor
  5. pertuzumab Antineoplastic and immunomodulating agents (L01)
  6. trastuzumab Antineoplastic and immunomodulating agents (L01)

Frequently asked questions

What is herceptin?

herceptin is a receptor protein-tyrosine kinase erbb-2 inhibitor.